IMMUNOLOGICAL OPTIMIZATION OF DIAGNOSIS METHODS FOR INTRAUTERINE GROWTH RETARDATION

Intrauterine growth retardation.

The recognition that some low birthweight babies (<2500 g) were the victims of intrauterine growth retardation rather than premature birth was a milestone in perinatal medicine.'3 Up to 10% of all liveborn babies and at least 30% of those of low birth weight suffer from intrauterine growth retardation; their perinatal mortality is four to 10 times higher than that of normally grown babies-both ...

Intrauterine Growth Retardation

Intrauterine growth retardation (IUGR) refers to fetal growth that has been constrained in utero. It results in newborns that have not attained their full growth potential and are already malnourished at birth. Fetuses that suffer from growth retardation have higher perinatal morbidity and mortality and are more likely to experience poor cognitive development and neurologic impairment during ch...

Dichorionic twins discordant for intrauterine growth retardation.

A policy of expectant management until 32 weeks of gestation in 29 dichorionic pregnancies discordant for growth retardation resulted in an overall mortality of 24% (95% CI 13.9-37.2%) and a handicap of 2.2% (95% CI 0-12.0%). None of the normally grown co-twins died or was handicapped as a result of iatrogenic prematurity.

Modern management of intrauterine growth retardation.

Management of intrauterine growth retardation is an important issue in obstetric practice. Since the introduction of Doppler ultrasonography, the problems associated with screening, diagnosing, monitoring, and identifying foetuses at risk have decreased in recent years. Owing to the use of Doppler ultrasonography, there is now a trend towards early delivery.

Some biochemical aspects of intrauterine growth retardation.